Mass spectrometry-based serum proteomic signature as a potential biomarker for survival in patients with non-small cell lung cancer receiving immunotherapy

VeriStrat test is a serum assay which uses a mass spectrometry (MS)-based proteomic signature derived from machine learning. It is currently used as a prognostic marker for patients with non-small cell lung cancer (NSCLC) receiving chemotherapy. However, little is known about its role for NSCLC pati...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Translational lung cancer research 2020-08, Vol.9 (4), p.1015-1028
Hauptverfasser:	Chae, Young Kwang, Kim, Won Bin, Davis, Andrew A, Park, Lee Chun, Anker, Jonathan F, Simon, Nicholas I, Rhee, Kyunghoon, Song, Junho, Cho, Anderson, Chang, Sangmin, Ko, Taeyeong, Oh, Michael, Bhave, Manali, Viveiros, Pedro
Format:	Artikel
Sprache:	eng
Schlagworte:	Original
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!